To study the effect of Kanchanara and Madhunashini two ayurvedic drug in treatment of the advanced oral cancer.
Phase 2
- Conditions
- Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/05/033332
- Lead Sponsor
- Yenepoya Deemed to be University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Oral squamous cell carcinoma (OSCC) patients with progressive disease who have completed definitive treatment
- OSCC patients coming with a local recurrence after a disease-free interval of more than 6 months, who are not amenable for any standard treatment
- Adult patients above the age of 18 years
- Patients with good physical performance status
- Patients who are able to give an informed consent
Exclusion Criteria
- Patients who can have conventional anti-cancer therapy
- Patients who are not willing to participate in the trial
- Patients who have grade IV Trismus
- Patients with poor performance status
- Patients who are younger than 18 years
- Patients who are unable to give an informed consent due to poor mental status
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in the Quality of life of oral cancer patient.Timepoint: Clinical assessment will be done at the end of 3rd, 6th, 9th and 12th month. Radiological assessment will be done at the end of one year. Quality of life with respect to the mentioned parameters will be addressed during the above intervals.
- Secondary Outcome Measures
Name Time Method Increase in the Quality of life of oral cancer patient.Timepoint: Quality of life with respect to the mentioned parameters will be addressed during the above intervals.